Exome Asset Management’s Verastem VSTM Stock Holding History

Exome Asset Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Buy	636,700 +234,957	+58%	+$1.45M	1.75%	22
2025 Q4	$3.1M	Buy	+401,743	New	+$3.58M	1.48%	29
2025 Q3	–	Sell	-599,900	Closed	-$2.49M	–	96
2025 Q2	$2.49M	Buy	+599,900	New	+$3.76M	1.85%	20

Other funds holding VSTM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Exome Asset Management's VSTM Position: Q1 2026 in Review

Exome Asset Management increased its Verastem (VSTM) stake by 58% in Q1 2026, buying an estimated $1.45M and bringing the position to 636,700 shares worth $3.37M. The position accounts for 1.75% of the portfolio, ranked #22.

Exome Asset Management first reported a position in VSTM in Q2 2025 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

Exome Asset Management held 636,700 shares of Verastem worth $3.37M as of Q1 2026.
Exome Asset Management bought 234,957 Verastem shares in Q1 2026, an estimated $1.45M.
Verastem made up 1.75% of Exome Asset Management's portfolio in Q1 2026, its #22 holding.
Exome Asset Management first reported a position in Verastem in Q2 2025 and has held it in 3 quarters since.
155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.